NASDAQ
393.25USD
+9.71 (+2.53%)
We have scored 88 news catalysts on Intuitive Surgical, Inc. (ISRG) over the past 12 months. The biggest single-day move next to one of them came Jul 16, 2026, when ISRG closed +3.4%: “Economist: “The Biggest Threat” to Inflation Isn't Buried in the June CPI Report”. Coverage across the window leans positive (average ticker sentiment +0.43). Most of the impact sits in sector healthcare and pricing power structural.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
139B
P/E
—
EPS
—
Beta
1.47
52W range
328.57-603.88
Day range
379.50–394.53
Open
381.84
Prev close
383.54
Volume
2M
Avg volume
2.9M
Dividend
0.00
IPO
2000-06-16
Analysts publish price targets on ISRG, and they disagree. Where the share price actually sits among them shows which of their arguments the market is buying — and which it is ignoring.
20 analyst price targets from $357 to $670
as of 2026-08-26
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Intuitive Surgical, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Suppliers, customers, partners and competitors of Intuitive Surgical, Inc., taken from what the news actually said about them rather than from a sector bucket. The count is how many articles established each link.
Latest scored catalyst for ISRG: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.
The reconstruction
At $393, the stock sits at the 5th percentile of published analyst targets, meaning the market firmly rejects the bull case and prices the company as if the current growth deceleration is permanent rather than a temporary slowdown.
What the disagreement turns on
Will U.S. da Vinci procedure growth re-accelerate above 18% as the bull models require, or has it structurally settled at the 13.5-15.5% guided range? This is directly testable via quarterly unit volume data.
The price pays for
It declines to pay for
Written by a language model from the published models, the reported segments and a reverse-DCF — not a recommendation, and not a house view.
Claim by claim
Computed at $372 on 2026-08-26 — the quote has since moved +6%, so read this as a record of what was priced in then, not now.
